To find out whether these in vitro findings could be replicated in MM patient samples, we investigated whether MM patients with cyclin D1 overexpression also exhibited significantly higher protein levels of ZO‐1, STAT1, and FLNA compared to patients without detectable cyclin D protein expression. The gene discussed is CCND1; the disease is Miyoshi myopathy.